This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Influenza mRNA Vaccines
April 27, 2023
Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST
Key Sessions
Raffael Nachbagauer
Development of mRNA-Based Seasonal Influenza Vaccines
Moderna, USA
Amita Vaidya
Rational Design and Optimization of mRNA-LNP Vaccines for Influenza
Sanofi, USA
Norbert Pardi
Broadly Protective Influenza Vaccines using Nucleoside-Modified mRNA
University of Pennsylvania, USA
Lawrence Thompson
Challenges and Current Approaches Concerning RNA Analytics for the Successful Development of mRNA Vaccines
Pfizer, USA